Price: $ 1295
BMI View: Disparity in the official and black market currency exchange rates, corruption and continual political tensions between Sudan and South Sudan will remain as downside risks to investments into the pharmaceutical sector. Consequently, we do not expect the market to be of particular interest to foreign pharmaceutical players. Headline Expenditure Projections ? Pharmaceuticals: SDG1.92bn (US$540mn) in 2012 to SDG2.37bn (US$500mn) in 2013; +23.6% in local currency terms with a contraction of -7.1% in US dollar terms. Forecast broadly in line with Q413, growth contractions in US dollar terms due to currency fluctuations. ...
Complete report details with Table of Contents and more @ http://www.marketreportsonline.com/295115.html
No comments:
Post a Comment